Covid vaccine maker CureVac in talks to sell 405M doses

The biotech is in discussions to provide up to 405 million doses of its experimental drug to European countries.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.